Pendulum Therapeutics is the leading innovator in microbiome science, delivering research based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel species to be brought to the probiotics market in more than 50 years. The first and only probiotic in the world clinically proven to lower A1C and blood glucose in people with type 2 diabetes, Akkermansia stimulates natural GLP-1 production.
| Website | https://pendulumlife.com/ |
| Revenue | $8.8 million |
| Funding | $10.5 million |
| Employees | 113 (113 on RocketReach) |
| Founded | 2012 |
| Address | 933 20th St, San Francisco, California 94107, US |
| Phone | (617) 669-9035 |
| Industry | Biotechnology, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Drug Discovery, Healthcare, Health Diagnostics, Health Care, Life Science, Medical, Therapeutics |
| Keywords | Human Microbiome, Microbiome Therapeutics, Gut Health, Probiotics, Bacterial Strains, Digestive Health, Microbiome Modulation, Natural Therapies, Precision Medicine, Disease Treatment, Targeted Therapies, Immune System, Biotechnology, Pharmaceutical Research, Health And Wellness, Scientific Research, Drug Development, Clinical Trials |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Pendulum Therapeutics employee's phone or email?
The Pendulum Therapeutics annual revenue was $8.8 million in 2026.
Andrey Reznik is the CFO of Pendulum Therapeutics.
113 people are employed at Pendulum Therapeutics.
Pendulum Therapeutics is based in San Francisco, California.
The NAICS codes for Pendulum Therapeutics are [32, 32541, 325, 3254].
The SIC codes for Pendulum Therapeutics are [283, 2834, 28].